Chief Strategy Officer (CSO)

The Company is seeking a senior scientific leader to guide oncology drug discovery and support the global development of cancer treatments. Responsibilities include planning nonclinical pharmacology studies, managing external research and data quality, evaluating drug efficacy, identifying biomarkers, and developing patient stratification strategies. The role also involves connecting nonclinical findings with clinical analyses, building scientific rationales and regulatory-ready data packages, and contributing to development decisions from IND through clinical trials. The successful candidate will communicate scientific findings to investors and other external stakeholders. Candidates should have approximately 10 or more years of oncology pharmacology research and development experience involving small-molecule compounds, along with expertise in translational research and biomarker discovery. A track record of advancing nonclinical projects into clinical development is required, as is a PhD. Fluency in Japanese and business-level English sufficient for advanced scientific discussions are essential. Experience with patient stratification, regulatory interactions, development decisions, and scientific communication is preferred, as is expert knowledge of relevant cellular metabolism and signaling mechanisms.